Dealings in securities by directors and a director of a major subsidiary LIFE HEALTHCARE GROUP HOLDINGS LIMITED (Incorporated in the Republic of South Africa) (Registration number: 2003/002733/06) ISIN: ZAE000145892 Share code: LHC (“Life Healthcare” or “the Company”) DEALINGS IN SECURITIES BY DIRECTORS AND A DIRECTOR OF A MAJOR SUBSIDIARY In compliance with the JSE Limited Listings Requirements, Life Healthcare shareholders are hereby advised of the following purchases made by the Group Chief Executive Officer and director of the Company, Peter Warton-Hood, and the Chief Financial Officer – South Africa, Megandra Naidoo who is a director of a major subsidiary. In addition, shareholders are referred to the SENS announcement made on 2 April 2020, where the market was advised of the shares awarded to a director of a major subsidiary and the Chief Executive Officer, South Africa, Mr Adam Pyle in terms of a bespoke retention share scheme. These shares recently vested, and Mr Pyle has elected to retain the shares but sell a portion to cover tax and costs associated with the vesting of the shares. Below are the details in relation to the respective purchases and sale of shares by the directors: Name of director : Peter Wharton-Hood Name of Company : Life Healthcare Group Holdings Nature of transaction : On market purchase of shares by the director Date of transaction : 26 November 2021 Number of securities : 200 000 Class of securities : Ordinary shares Total value of transaction : R4 453 341.09 Purchase price per share : R22.27 Nature of interest : Direct beneficial Clearance obtained : Yes Name of director : Megandra Naidoo Name of Company : Life Healthcare Group (Pty) Ltd Nature of transaction : On market purchase of shares by the director Date of transaction : 29 November 2021 Number of securities purchased : 23 750 Class of securities : Ordinary shares Total value of transaction : R545 900.00 Volume-weighted average purchase price per share : R22.99 Highest purchase price per share : R23.10 Lowest purchase price per share : R22.79 Nature of interest : Direct beneficial Clearance obtained : Yes Date of transaction : 30 November 2021 Number of securities purchased : 20 000 Class of securities : Ordinary shares Total value of transaction : R468 382.52 Volume-weighted average of purchase price per share : R23.42 Highest purchase price per share : R23.46 Lowest purchase price per share : R23.35 Nature of interest : Direct beneficial Clearance obtained : Yes Name of director : Adam Pyle Name of Company : Life Healthcare Group Holdings Nature of transaction : On market sale of shares by the director Date of transaction : 30 November 2021 Number of securities : 38 404 Class of securities : Ordinary shares Total value of transaction : R898 933.95 Volume-weighted average of selling price per share : R23.41 Highest selling price per share : R23.43 Lowest selling price per share : R23.40 Nature of interest : Direct beneficial Clearance obtained : Yes Dunkeld 2 December 2021 Sponsor RAND MERCHANT BANK (A division of FirstRand Bank Limited) Date: 02-12-2021 04:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.